NeoPharm CO., LTD. (KOSDAQ: 092730)
South Korea
· Delayed Price · Currency is KRW 23,400
+200 (0.86%)
Sep 11, 2024, 3:19 PM KST
NeoPharm CO., LTD. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 182,612 | 202,163 | 150,156 | 193,952 | 223,279 | 378,127 | Upgrade
|
| Market Cap Growth | 13.87% | 34.64% | -22.58% | -13.13% | -40.95% | 16.02% | Upgrade
|
| Enterprise Value | 73,260 | 78,166 | 45,545 | 97,728 | 138,586 | 299,544 | Upgrade
|
| Last Close Price | 23350.00 | 25850.00 | 18640.78 | 23232.84 | 26008.78 | 43050.56 | Upgrade
|
| PE Ratio | 7.96 | 8.71 | 8.56 | 10.26 | 11.33 | 16.92 | Upgrade
|
| PS Ratio | 1.69 | 2.08 | 1.77 | 2.21 | 2.74 | 4.54 | Upgrade
|
| PB Ratio | 1.10 | 1.26 | 1.06 | 1.49 | 1.90 | 3.58 | Upgrade
|
| P/FCF Ratio | -67.76 | 59.27 | 8.48 | 9.08 | 13.30 | 28.38 | Upgrade
|
| P/OCF Ratio | 13.07 | 8.69 | 8.27 | 8.95 | 13.08 | 19.67 | Upgrade
|
| EV/Sales Ratio | 0.68 | 0.80 | 0.54 | 1.11 | 1.70 | 3.60 | Upgrade
|
| EV/EBITDA Ratio | 2.69 | 2.90 | 1.98 | 4.08 | 5.92 | 12.39 | Upgrade
|
| EV/EBIT Ratio | 2.94 | 3.09 | 2.12 | 4.36 | 6.33 | 13.05 | Upgrade
|
| EV/FCF Ratio | -21.48 | 22.92 | 2.57 | 4.58 | 8.25 | 22.49 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.01 | 0.00 | 0.00 | 0.04 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.04 | 0.02 | 0.02 | 0.18 | 0.19 | Upgrade
|
| Debt / FCF Ratio | -0.24 | 0.31 | 0.02 | 0.03 | 0.26 | 0.35 | Upgrade
|
| Asset Turnover | 0.63 | 0.58 | 0.57 | 0.64 | 0.64 | 0.85 | Upgrade
|
| Inventory Turnover | 3.79 | 3.35 | 3.19 | 3.18 | 3.30 | 3.65 | Upgrade
|
| Quick Ratio | 7.99 | 7.22 | 9.22 | 8.74 | 7.06 | 7.41 | Upgrade
|
| Current Ratio | 8.93 | 7.94 | 9.99 | 9.39 | 7.63 | 7.92 | Upgrade
|
| Return on Equity (ROE) | 14.55% | 15.36% | 12.50% | 14.28% | 16.23% | 23.33% | Upgrade
|
| Return on Assets (ROA) | 9.05% | 9.51% | 8.97% | 10.14% | 10.71% | 14.67% | Upgrade
|
| Return on Capital (ROIC) | 9.84% | 10.42% | 9.80% | 11.09% | 11.78% | 16.87% | Upgrade
|
| Earnings Yield | 12.56% | 11.48% | 11.34% | 9.13% | 8.12% | 5.09% | Upgrade
|
| FCF Yield | -1.87% | 1.69% | 11.79% | 11.01% | 7.52% | 3.52% | Upgrade
|
| Dividend Yield | 3.23% | 2.90% | 3.76% | 3.01% | 2.50% | 1.74% | Upgrade
|
| Payout Ratio | 25.58% | 23.58% | 32.15% | 28.70% | 32.35% | 23.89% | Upgrade
|
| Buyback Yield / Dilution | 0.01% | - | - | 0.95% | -4.38% | -5.80% | Upgrade
|
| Total Shareholder Return | 3.24% | 2.90% | 3.76% | 3.96% | -1.88% | -4.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.